{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:43Z","timestamp":1786985083518,"version":"build-2736575974"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC112-2320-B110-003"],"award-info":[{"award-number":["NSTC112-2320-B110-003"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bcp.2024.116242","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T02:34:16Z","timestamp":1714098856000},"page":"116242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["ONC212 enhances YM155 cytotoxicity by triggering SLC35F2 expression and NOXA-dependent MCL1 degradation in acute myeloid leukemia cells"],"prefix":"10.1016","volume":"224","author":[{"given":"Jing-Ting","family":"Chiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Sen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116242_b0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.bcp.2024.116242_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114253","article-title":"Targeting mitochondrial respiration for the treatment of acute myeloid leukemia","volume":"182","author":"Carter","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116242_b0015","doi-asserted-by":"crossref","first-page":"24734","DOI":"10.18632\/aging.202361","article-title":"Biological characteristics of aging in human acute myeloid leukemia cells: the possible importance of aldehyde dehydrogenase, the cytoskeleton and altered transcriptional regulation","volume":"12","author":"Hernandez-Valladares","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.bcp.2024.116242_b0020","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41375-023-01835-x","article-title":"Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia","volume":"37","author":"Larrue","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2024.116242_b0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40170-021-00253-w","article-title":"Mitochondrial metabolism as a target for acute myeloid leukemia treatment","volume":"9","author":"Panina","year":"2021","journal-title":"Cancer Metab."},{"key":"10.1016\/j.bcp.2024.116242_b0030","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/s43018-021-00264-y","article-title":"Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia","volume":"2","author":"Bosc","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bcp.2024.116242_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41375-021-01416-w","article-title":"Mitochondrial metabolism as a potential therapeutic target in myeloid leukaemia","volume":"36","author":"de Beauchamp","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2024.116242_b0040","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.tips.2020.09.004","article-title":"BH3 mimetics in AML therapy: death and beyond?","volume":"41","author":"Cerella","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2024.116242_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.584974","article-title":"Targeting Bcl-2 proteins in acute myeloid leukemia","volume":"10","author":"Wei","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2024.116242_b0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3324\/haematol.2020.260331","article-title":"Targeting MCL-1 dysregulates cell metabolism and leukemia-stroma interactions and resensitizes acute myeloid leukemia to BCL-2 inhibition","volume":"107","author":"Carter","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.bcp.2024.116242_b0055","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","article-title":"Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia","volume":"24","author":"Pollyea","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2024.116242_b0060","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/2159-8290.CD-19-0117","article-title":"Targeting mitochondrial structure sensitizes acute myeloid leukemia to venetoclax treatment","volume":"9","author":"Chen","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bcp.2024.116242_b0065","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax2863","article-title":"Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress response","volume":"11","author":"Sharon","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2024.116242_b0070","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1021\/acschembio.9b00222","article-title":"Mitochondrial protease ClpP is a target for the anticancer compounds ONC201 and related analogues","volume":"14","author":"Graves","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bcp.2024.116242_b0075","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/neuonc\/noaa283","article-title":"Mechanisms of imipridones in targeting mitochondrial metabolism in cancer cells","volume":"23","author":"Bonner","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bcp.2024.116242_b0080","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neo.2020.09.005","article-title":"ONC201 and imipridones: anti-cancer compounds with clinical efficacy","volume":"22","author":"Prabhu","year":"2020","journal-title":"Neoplasia"},{"key":"10.1016\/j.bcp.2024.116242_b0085","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1080\/15384101.2017.1325046","article-title":"Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212","volume":"16","author":"Wagner","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcp.2024.116242_b0090","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1038\/s41375-019-0491-z","article-title":"Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia","volume":"33","author":"Nii","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2024.116242_b0095","first-page":"5374","article-title":"Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer","volume":"11","author":"Staley","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bcp.2024.116242_b0100","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ccell.2019.03.014","article-title":"Mitochondrial ClpP-mediated proteolysis induces selective cancer cell lethality","volume":"35","author":"Ishizawa","year":"2019","journal-title":"Cancer Cell"},{"issue":"ra17","key":"10.1016\/j.bcp.2024.116242_b0105","article-title":"ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies","volume":"9","author":"Ishizawa","year":"2016","journal-title":"Sci. Signal."},{"issue":"ra18","key":"10.1016\/j.bcp.2024.116242_b0110","article-title":"ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2\u03b1 kinases","volume":"9","author":"Kline","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bcp.2024.116242_b0115","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1158\/1535-7163.MCT-20-0962","article-title":"ONC212 is a novel mitocan acting synergistically with glycolysis inhibition in pancreatic cancer","volume":"20","author":"Ferrarini","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bcp.2024.116242_b0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/jha2.160","article-title":"The ClpP activator ONC-212 (TR-31) inhibits BCL2 and B-cell receptor signaling in CLL","volume":"2","author":"Fatima","year":"2021","journal-title":"Ejhaem"},{"key":"10.1016\/j.bcp.2024.116242_b0125","doi-asserted-by":"crossref","first-page":"81776","DOI":"10.18632\/oncotarget.20819","article-title":"Anti-pancreatic cancer activity of ONC212 involves the unfolded protein response (UPR) and is reduced by IGF1-R and GRP78\/BIP","volume":"8","author":"Lev","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2024.116242_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114544","article-title":"Inhibition of Sp1-mediated survivin and MCL1 expression cooperates with SLC35F2 and myeloperoxidase to modulate YM155 cytotoxicity to human leukemia cells","volume":"188","author":"Chiou","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116242_b0135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12935-016-0326-1","article-title":"Survivin: a unique target for tumor therapy","volume":"16","author":"Garg","year":"2016","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bcp.2024.116242_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109978","article-title":"BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells","volume":"361","author":"Chiou","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2024.116242_b0145","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2024.116242_b0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10565-019-09495-3","article-title":"Compound C induces autophagy and apoptosis in parental and hydroquinone-selected malignant leukemia cells through the ROS\/p38 MAPK\/AMPK\/TET2\/FOXP3 axis","volume":"36","author":"Chiou","year":"2020","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.bcp.2024.116242_b0155","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ijbiomac.2021.07.133","article-title":"Carboxyl group-modified \u03b1-lactalbumin induces TNF-\u03b1-mediated apoptosis in leukemia and breast cancer cells through the NOX4\/p38 MAPK\/PP2A axis","volume":"187","author":"Chiou","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bcp.2024.116242_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115442","article-title":"AMPK inhibition induces MCL1 mRNA destabilization via the p38 MAPK\/miR-22\/HuR axis in chronic myeloid leukemia cells","volume":"209","author":"Lee","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116242_b0165","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10495-023-01918-1","article-title":"Synergistic cytotoxicity of decitabine and YM155 in leukemia cells through upregulation of SLC35F2 and suppression of MCL1 and survivin expression","volume":"29","author":"Chiou","year":"2023","journal-title":"Apoptosis"},{"key":"10.1016\/j.bcp.2024.116242_b0170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.taap.2017.08.019","article-title":"Quinacrine induces the apoptosis of human leukemia U937 cells through FOXP3\/miR-183\/\u03b2-TrCP\/SP1 axis-mediated BAX upregulation","volume":"334","author":"Huang","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116242_b0175","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-genet-102108-134850","article-title":"The role of mitochondria in apoptosis*","volume":"43","author":"Wang","year":"2009","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.bcp.2024.116242_b0180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/cdd.2017.186","article-title":"BCL-2 family proteins: changing partners in the dance towards death","volume":"25","author":"Kale","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2024.116242_b0185","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.1073\/pnas.0701297104","article-title":"Structural insights into the degradation of Mcl-1 induced by BH3 domains","volume":"104","author":"Czabotar","year":"2007","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2024.116242_b0190","doi-asserted-by":"crossref","first-page":"28342","DOI":"10.18632\/oncotarget.16058","article-title":"Artocarpin, an isoprenyl flavonoid, induces p53-dependent or independent apoptosis via ROS-mediated MAPKs and Akt activation in non-small cell lung cancer cells","volume":"8","author":"Tsai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2024.116242_b0195","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.3390\/cells9071740","article-title":"The lipid receptor G2A (GPR132) mediates macrophage migration in nerve injury-induced neuropathic pain","volume":"9","author":"Osthues","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2024.116242_b0200","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.15252\/embr.201642195","article-title":"The integrated stress response","volume":"17","author":"Pakos-Zebrucka","year":"2016","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bcp.2024.116242_b0205","doi-asserted-by":"crossref","first-page":"26495","DOI":"10.1074\/jbc.M112.376319","article-title":"Transcription factors Sp1 and p73 control the expression of the proapoptotic protein NOXA in the response of testicular embryonal carcinoma cells to cisplatin","volume":"287","author":"Grande","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116242_b0210","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/1878-0261.12172","article-title":"p53-independent Noxa induction by cisplatin is regulated by ATF3\/ATF4 in head and neck squamous cell carcinoma cells","volume":"12","author":"Sharma","year":"2018","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bcp.2024.116242_b0215","article-title":"ONC206, an imipridone derivative, induces cell death through activation of the integrated stress response in serous endometrial cancer in vitro","volume":"10","author":"Zhang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2024.116242_b0220","article-title":"Anti-tumor and anti-invasive effects of ONC201 on ovarian cancer cells and a transgenic mouse model of serous ovarian cancer","volume":"12","author":"Fan","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2024.116242_b0225","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrm2256","article-title":"ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis","volume":"8","author":"D'Autr\u00e9aux","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2024.116242_b0230","doi-asserted-by":"crossref","first-page":"34609","DOI":"10.1074\/jbc.M507802200","article-title":"Interaction of RNA-binding proteins HuR and AUF1 with the human ATF3 mRNA 3'-untranslated region regulates its amino acid limitation-induced stabilization","volume":"280","author":"Pan","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116242_b0235","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1091\/mbc.e07-07-0675","article-title":"Polyamines regulate the stability of activating transcription factor-2 mRNA through RNA-binding protein HuR in intestinal epithelial cells","volume":"18","author":"Xiao","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bcp.2024.116242_b0240","doi-asserted-by":"crossref","first-page":"27118","DOI":"10.1074\/jbc.M114.568717","article-title":"Activating transcription factor 3-mediated chemo-intervention with cancer chemokines in a noncanonical pathway under endoplasmic reticulum stress","volume":"289","author":"Park","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116242_b0245","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nchembio.1590","article-title":"The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity","volume":"10","author":"Winter","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bcp.2024.116242_b0250","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00204-016-1753-4","article-title":"Hydroquinone-induced FOXP3-ADAM17-Lyn-Akt-p21 signaling axis promotes malignant progression of human leukemia U937 cells","volume":"91","author":"Chen","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bcp.2024.116242_b0255","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.taap.2018.09.008","article-title":"The suppressive effect of arsenic trioxide on TET2-FOXP3-Lyn-Akt axis-modulated MCL1 expression induces apoptosis in human leukemia cells","volume":"358","author":"Chen","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116242_b0260","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/bcp.13021","article-title":"AKT in cancer: new molecular insights and advances in drug development","volume":"82","author":"Mundi","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116242_b0265","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1172\/JCI62279","article-title":"mTORC1 is essential for leukemia propagation but not stem cell self-renewal","volume":"122","author":"Hoshii","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2024.116242_b0270","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.3390\/cancers14143557","article-title":"NF-\u03baB: A druggable target in acute myeloid leukemia","volume":"14","author":"Di Francesco","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2024.116242_b0275","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jcp.29884","article-title":"GSK3\u03b2 suppression inhibits MCL1 protein synthesis in human acute myeloid leukemia cells","volume":"236","author":"Lee","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2024.116242_b0280","doi-asserted-by":"crossref","first-page":"171ra17","DOI":"10.1126\/scitranslmed.3004828","article-title":"Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects","volume":"5","author":"Allen","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2024.116242_b0285","doi-asserted-by":"crossref","first-page":"e85898","DOI":"10.7554\/eLife.85898","article-title":"ONC201\/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer","volume":"12","author":"Farmaki","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2024.116242_b0290","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s41419-022-05434-z","article-title":"Activation of orphan receptor GPR132 induces cell differentiation in acute myeloid leukemia","volume":"13","author":"Yi","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2024.116242_b0295","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/s42003-021-02564-6","article-title":"The multiple mechanisms of MCL1 in the regulation of cell fate","volume":"4","author":"Widden","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.bcp.2024.116242_b0300","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s10565-022-09705-5","article-title":"Effects of SIDT2 on the miR-25\/NOX4\/HuR axis and SIRT3 mRNA stability lead to ROS-mediated TNF-\u03b1 expression in hydroquinone-treated leukemia cells","volume":"39","author":"Wang","year":"2023","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.bcp.2024.116242_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116625","article-title":"Amsacrine downregulates BCL2L1 expression and triggers apoptosis in human chronic myeloid leukemia cells through the SIDT2\/NOX4\/ERK\/HuR pathway","volume":"474","author":"Lee","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116242_b0310","doi-asserted-by":"crossref","first-page":"46144","DOI":"10.1038\/srep46144","article-title":"NOX4 regulates CCR2 and CCL2 mRNA stability in alcoholic liver disease","volume":"7","author":"Sasaki","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2024.116242_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114865","article-title":"Docetaxel-triggered SIDT2\/NOX4\/JNK\/HuR signaling axis is associated with TNF-\u03b1-mediated apoptosis of cancer cells","volume":"195","author":"Wang","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116242_b0320","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1126\/science.aad0489","article-title":"mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle","volume":"351","author":"Ben-Sahra","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bcp.2024.116242_b0325","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.celrep.2017.04.042","article-title":"mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4","volume":"19","author":"Park","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2024.116242_b0330","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.semcdb.2023.06.006","article-title":"Cell death or survival: Insights into the role of mRNA translational control","volume":"154","author":"Bhatter","year":"2024","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2024.116242_b0335","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41418-019-0486-3","article-title":"Saga of Mcl-1: regulation from transcription to degradation","volume":"27","author":"Senichkin","year":"2020","journal-title":"Cell Death Differ."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224002259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224002259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T19:34:15Z","timestamp":1748633655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224002259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":67,"alternative-id":["S0006295224002259"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116242","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ONC212 enhances YM155 cytotoxicity by triggering SLC35F2 expression and NOXA-dependent MCL1 degradation in acute myeloid leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116242"}}